In vitro studies demonstrated that 6-MSITC induced apoptosis in human colorectal cancer cells by arresting the cell cycle in the G2/M phase via the ERK1/2-mediated ELK1/CHOP/DR5 pathway and in a p53-independent manner. Here, TP53 is linked to colorectal cancer.